AAAAAA

   
Results: 1-25 | 26-50 | 51-56 |
Results: 51-56/56

Authors: BOTSCH S HEINKELE G MEESE CO EICHELBAUM M KROEMER HK
Citation: S. Botsch et al., RAPID-DETERMINATION OF CYP2D6 PHENOTYPE DURING PROPAFENONE THERAPY BYANALYZING URINARY-EXCRETION OF PROPAFENONE GLUCURONIDES, European Journal of Clinical Pharmacology, 46(2), 1994, pp. 133-135

Authors: FUNCKBRENTANO C BECQUEMONT L KROEMER HK BUHL K KNEBEL NG EICHELBAUM M JAILLON P
Citation: C. Funckbrentano et al., VARIABLE DISPOSITION KINETICS AND ELECTROCARDIOGRAPHIC EFFECTS OF FLECAINIDE DURING REPEATED DOSING IN HUMANS - CONTRIBUTION OF GENETIC-FACTORS, DOSE-DEPENDENT CLEARANCE, AND INTERACTION WITH AMIODARONE, Clinical pharmacology and therapeutics, 55(3), 1994, pp. 256-269

Authors: KROEMER HK FROMM M BUHL K TEREFE H BLASCHKE G EICHELBAUM M
Citation: Hk. Kroemer et al., AN ENANTIOMER ENANTIOMER INTERACTION MODIFIES DRUG DISPOSITION AND ACTION OF THE ANTIARRHYTHMIC PROPAFENONE IN MAN/, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 208-208

Authors: KROEMER HK FROMM MF BUHL K TEREFE H BLASCHKE G EICHELBAUM M
Citation: Hk. Kroemer et al., AN ENANTIOMER-ENANTIOMER INTERACTION OF (S)-PROPAFENONE AND (R)-PROPAFENONE MODIFIES THE EFFECT OF RACEMIC DRUG-THERAPY, Circulation, 89(5), 1994, pp. 2396-2400

Authors: FRITZ P BEHRLE E BEAUNE P EICHELBAUM M KROEMER HK
Citation: P. Fritz et al., DIFFERENTIAL EXPRESSION OF DRUG-METABOLIZING-ENZYMES IN PRIMARY AND SECONDARY LIVER NEOPLASM - IMMUNOHISTOCHEMICAL CHARACTERIZATION OF CYTOCHROME-P4503A AND GLUTATHIONE-S-TRANSFERASE, Histochemistry, 99(6), 1993, pp. 443-451

Authors: KROEMER HK GAUTIER JC BEAUNE P HENDERSON C WOLF CR EICHELBAUM M
Citation: Hk. Kroemer et al., IDENTIFICATION OF P450 ENZYMES INVOLVED IN METABOLISM OF VERAPAMIL INHUMANS, Naunyn-Schmiedeberg's archives of pharmacology, 348(3), 1993, pp. 332-337
Risultati: 1-25 | 26-50 | 51-56 |